Masimo (NASDAQ:MASI) Research Coverage Started at Loop Capital

Loop Capital assumed coverage on shares of Masimo (NASDAQ:MASIGet Rating) in a research report report published on Tuesday morning, The Fly reports. The brokerage issued a buy rating on the medical equipment provider’s stock.

A number of other analysts have also recently weighed in on MASI. Needham & Company LLC raised their price objective on Masimo from $163.00 to $179.00 and gave the stock a buy rating in a research report on Wednesday, August 10th. Piper Sandler raised their price objective on Masimo from $130.00 to $135.00 and gave the stock a neutral rating in a research report on Wednesday, August 10th. Stifel Nicolaus raised their price objective on Masimo from $162.00 to $172.00 and gave the stock a buy rating in a research report on Monday. Finally, StockNews.com lowered Masimo from a buy rating to a hold rating in a research note on Wednesday, August 10th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $188.20.

Masimo Stock Down 6.5 %

Shares of NASDAQ MASI opened at $146.37 on Tuesday. The company has a current ratio of 2.10, a quick ratio of 1.28 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $7.69 billion, a PE ratio of 44.09 and a beta of 0.96. The stock’s fifty day simple moving average is $146.33 and its two-hundred day simple moving average is $141.20. Masimo has a 12-month low of $112.07 and a 12-month high of $305.21.

Masimo (NASDAQ:MASIGet Rating) last announced its earnings results on Tuesday, August 9th. The medical equipment provider reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.16. The business had revenue of $565.30 million for the quarter, compared to analysts’ expectations of $540.56 million. Masimo had a return on equity of 17.39% and a net margin of 12.68%. The business’s revenue for the quarter was up 87.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.94 EPS. As a group, analysts expect that Masimo will post 4.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Masimo

A number of institutional investors have recently modified their holdings of the stock. Arizona State Retirement System raised its stake in shares of Masimo by 0.5% during the 2nd quarter. Arizona State Retirement System now owns 14,679 shares of the medical equipment provider’s stock valued at $1,918,000 after buying an additional 76 shares during the last quarter. Lazard Asset Management LLC increased its stake in shares of Masimo by 20.0% in the 1st quarter. Lazard Asset Management LLC now owns 485 shares of the medical equipment provider’s stock valued at $70,000 after purchasing an additional 81 shares in the last quarter. Meeder Asset Management Inc. increased its stake in shares of Masimo by 61.3% in the 2nd quarter. Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 84 shares in the last quarter. CWM LLC increased its stake in shares of Masimo by 8.4% in the 2nd quarter. CWM LLC now owns 1,173 shares of the medical equipment provider’s stock valued at $153,000 after purchasing an additional 91 shares in the last quarter. Finally, State of Michigan Retirement System increased its stake in shares of Masimo by 0.8% in the 2nd quarter. State of Michigan Retirement System now owns 12,996 shares of the medical equipment provider’s stock valued at $1,698,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 93.31% of the company’s stock.

Masimo Company Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Articles

The Fly logo

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.